• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物代谢组学:数据处理与统计分析。

Pharmacometabonomics: data processing and statistical analysis.

机构信息

College of Pharmaceutical Sciences in Zhejiang University, China.

Department of Bioinformatics in Chongqing Medical University, China.

出版信息

Brief Bioinform. 2021 Sep 2;22(5). doi: 10.1093/bib/bbab138.

DOI:10.1093/bib/bbab138
PMID:33866355
Abstract

Individual variations in drug efficacy, side effects and adverse drug reactions are still challenging that cannot be ignored in drug research and development. The aim of pharmacometabonomics is to better understand the pharmacokinetic properties of drugs and monitor the drug effects on specific metabolic pathways. Here, we systematically reviewed the recent technological advances in pharmacometabonomics for better understanding the pathophysiological mechanisms of diseases as well as the metabolic effects of drugs on bodies. First, the advantages and disadvantages of all mainstream analytical techniques were compared. Second, many data processing strategies including filtering, missing value imputation, quality control-based correction, transformation, normalization together with the methods implemented in each step were discussed. Third, various feature selection and feature extraction algorithms commonly applied in pharmacometabonomics were described. Finally, the databases that facilitate current pharmacometabonomics were collected and discussed. All in all, this review provided guidance for researchers engaged in pharmacometabonomics and metabolomics, and it would promote the wide application of metabolomics in drug research and personalized medicine.

摘要

药物疗效、副作用和不良反应的个体差异仍然是药物研发中不可忽视的挑战。药物代谢组学的目的是更好地了解药物的药代动力学特性,并监测药物对特定代谢途径的影响。在这里,我们系统地回顾了药物代谢组学的最新技术进展,以更好地了解疾病的病理生理机制以及药物对身体的代谢影响。首先,比较了所有主流分析技术的优缺点。其次,讨论了许多数据处理策略,包括过滤、缺失值插补、基于质量控制的校正、转换、归一化以及每个步骤中实施的方法。第三,描述了药物代谢组学中常用的各种特征选择和特征提取算法。最后,收集并讨论了有助于当前药物代谢组学的数据库。总之,本综述为从事药物代谢组学和代谢组学的研究人员提供了指导,并将促进代谢组学在药物研究和个性化医学中的广泛应用。

相似文献

1
Pharmacometabonomics: data processing and statistical analysis.药物代谢组学:数据处理与统计分析。
Brief Bioinform. 2021 Sep 2;22(5). doi: 10.1093/bib/bbab138.
2
NMR-based pharmacometabonomics: A new paradigm for personalised or precision medicine.基于 NMR 的临床药代动力学组学:个性化或精准医学的新模式。
Prog Nucl Magn Reson Spectrosc. 2017 Nov;102-103:1-14. doi: 10.1016/j.pnmrs.2017.04.003. Epub 2017 May 6.
3
[Pharmacometabonomics - the novel way to personalized drug therapy].[药物代谢组学——个性化药物治疗的新途径]
Biomed Khim. 2017 Mar;63(2):115-123. doi: 10.18097/PBMC20176302115.
4
[Progress in the personalized medicine using pharmacometabonomics].[基于药物代谢组学的个性化医学研究进展]
Yao Xue Xue Bao. 2014 Nov;49(11):1491-7.
5
Translational Metabolomics of Head Injury: Exploring Dysfunctional Cerebral Metabolism with Ex Vivo NMR Spectroscopy-Based Metabolite Quantification头部损伤的转化代谢组学:基于体外核磁共振波谱的代谢物定量分析探索脑代谢功能障碍
6
Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy.纵向药代代谢组学预测患者对治疗的反应:药物代谢、毒性和疗效。
Expert Opin Drug Metab Toxicol. 2012 Feb;8(2):135-9. doi: 10.1517/17425255.2012.646987. Epub 2012 Jan 17.
7
Pharmacometabonomics and personalized medicine.药物代谢组学与个性化医学。
Ann Clin Biochem. 2013 Nov;50(Pt 6):523-45. doi: 10.1177/0004563213497929. Epub 2013 Jul 25.
8
The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?四种分析方法联合用于探索骨骼肌代谢组学:是更好地覆盖代谢途径,还是一个营销论点?
J Pharm Biomed Anal. 2018 Jan 30;148:273-279. doi: 10.1016/j.jpba.2017.10.013. Epub 2017 Oct 18.
9
Mass Spectrometry-Based Metabolomics.基于质谱的代谢组学
Methods Mol Biol. 2018;1775:107-118. doi: 10.1007/978-1-4939-7804-5_10.
10
Pharmacometabonomics in humans: a new tool for personalized medicine.人体药物代谢组学:个性化医疗的新工具。
Pharmacogenomics. 2015;16(7):737-54. doi: 10.2217/pgs.15.20. Epub 2015 May 1.

引用本文的文献

1
CD163-Mediated Small-Vessel Injury in Alzheimer's Disease: An Exploration from Neuroimaging to Transcriptomics.阿尔茨海默病中 CD163 介导的小血管损伤:从神经影像学到转录组学的探索。
Int J Mol Sci. 2024 Feb 14;25(4):2293. doi: 10.3390/ijms25042293.
2
Drug-microbiota interactions: an emerging priority for precision medicine.药物-微生物群相互作用:精准医学中一个新出现的优先事项。
Signal Transduct Target Ther. 2023 Oct 9;8(1):386. doi: 10.1038/s41392-023-01619-w.
3
Explainable artificial intelligence model for identifying COVID-19 gene biomarkers.
用于识别 COVID-19 基因生物标志物的可解释人工智能模型。
Comput Biol Med. 2023 Mar;154:106619. doi: 10.1016/j.compbiomed.2023.106619. Epub 2023 Feb 1.
4
DrugMAP: molecular atlas and pharma-information of all drugs.DrugMAP:所有药物的分子图谱和药物信息。
Nucleic Acids Res. 2023 Jan 6;51(D1):D1288-D1299. doi: 10.1093/nar/gkac813.
5
DRESIS: the first comprehensive landscape of drug resistance information.DRESIS:首个全面的耐药性信息全景图。
Nucleic Acids Res. 2023 Jan 6;51(D1):D1263-D1275. doi: 10.1093/nar/gkac812.
6
A Review of Performance Prediction Based on Machine Learning in Materials Science.基于机器学习的材料科学性能预测综述
Nanomaterials (Basel). 2022 Aug 26;12(17):2957. doi: 10.3390/nano12172957.
7
Diagnosis and prognosis of COVID-19 employing analysis of patients' plasma and serum via LC-MS and machine learning.利用 LC-MS 和机器学习分析患者的血浆和血清诊断和预测 COVID-19。
Comput Biol Med. 2022 Jul;146:105659. doi: 10.1016/j.compbiomed.2022.105659. Epub 2022 May 21.
8
Pharmacokinetic-Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes.早期临床试验中的药代动力学-药物代谢组学方法:2型糖尿病靶向治疗的前进之路
Pharmaceutics. 2022 Jun 15;14(6):1268. doi: 10.3390/pharmaceutics14061268.